Risk Factors of Developing a Second Malignancy Following Treatment of a First Primary Breast Cancer

Ahmad Rezazadeh Mafi--- ,
Shadi Babazadeh--- ,
Fatemeh Homaee Shandiz--- ,
Zahra Razzaghi--- ,
Morteza Tabatabaeefar--- ,
Sara Sobhi--- ,
Mohammad Esmaeil Akbari---

Abstract


168

Abstract

Background: Breast cancer is the most prevalent cancer among Iranian women, and is the fifth cause of cancer-related death in Iran. Most studies have reported an overall excess of 20–30% chance for a second primary cancer to develop in individuals with a first breast cancer. In this study, we evaluated different factors might have a role in increasing the incidence of a second malignancy after a first primary breast cancer in Iran.

Methods: We considered 980 breast cancer patients from three cancer research centers in Tehran, Mashad and Isfahan from Sep 1995 till Sep 2010.

Results: Overall, 94 second primary neoplasms observed. This analysis showed the existence of a modest excess in several neoplasms occurring after breast cancer. Some treatment related factors, including radiotherapy or mastectomy, had statistically significant relation with development a secondary cancer. However, sub-analysis failed to prove such a relationship.

Conclusion: Therefore, we can concluded that the risk of developing a second cancer is more dependent on genetic and environmental factors that caused the first primary cancer, rather than being dependent on type of treatment and other factors mentioned in this study.

Keywords: Breast cancer; Second primary; Therapy; Iran

1. Levi F, Te VC, Randimbison L, La Vecchia C. Cancer risk in women with previous breast cancer. Ann Oncol. 2003 Jan; 14(1):71-3.2. Mellemkjaer L, Friis S, Olsen JH, Scélo G, Hemminki K, Tracey E, et. al. Risk of second cancer among women with breast cancer. Int J Cancer. 2006 May 1; 118(9):2285-92.3. Evans HS, Lewis CM, Robinson D, Bell CM, Møller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer. 2001 Feb 2; 84(3):435-40.4. Akbari ME, Khaymzadeh M, Khoshnevis SJ, Nafisi N, Akbari A. Five and ten year survival in breast cancer patients: mastectomy vs breast conserving surgeries. Personal experience. IJCP. 2008; 1(2): 53-6.5. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996.Int J Cancer. 2001 ;93(2):155-61.6. Schenker JG, Levinsky R, Ohel G. Multiple primary malignant neoplasms in breast cancer patients in Israel.Cancer. 1984; 54(1):145-50.7. Akbari ME, Motlagh AG, Khayamzadeh M, Abachizadeh K, Tabatabaee M, Esnaashari F, et al. Iran Cancer Report, 1st ed. Cancer Research Center, SBMU. 2008 (Book in Persian).

8. Stromberg TV. Chemotherapy-induced secondary malignancies. J Infus Nurs. 2003; 26(6):353-61.

9. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG.Increased risk of second cancers following breast cancer: role of the initial treatment.Breast Cancer Res Treat. 2000; 61(3):183-95.10. Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy.J Clin Oncol. 2000 Jun; 18(12):2406-12.

11. Mery CM, George S, Bertagnolli MM, Raut CP. Secondary Sarcomas AfterRadiotherapy for Breast Cancer: Sustained Risk and Poor Survival. Cancer. 2009; 115:4055-63.

12. Johansen S, Danielsen T, Olsen DR.Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.Acta Oncol. 2008; 47(3):391-6.

13. Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 2001; 92:1411-8.

14. Tanaka H, Tsukuma H, Koyama H, Kinoshita Y, Kinoshita N, Oshima A. Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res. 2001; 92:1-8.


Full Text:

PDF

157